Tech Company Financing Transactions
Evonetix Funding Round
Evonetix, based in Cambridge, secured $24 million from Foresite Capital, Cambridge Consultants and Civilization Ventures.
Transaction Overview
Company Name
Announced On
2/8/2023
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for the continued development of its semiconductor chips to commercial scale, and the extension of gene assembly capabilities for its binary assembly technology to deliver accurate, gene-length DNA in a benchtop instrument.
Company Information
Company Status
Private & Independent
Industry
Semiconductors
Mailing Address
9a Coldham's Business Park Norman Way,
Cambridge, CB1 3LH
UK
Cambridge, CB1 3LH
UK
Phone
Website
Email Address
Overview
Evonetix is a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use biology on a scale not currently possible.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Beastall
Chief Executive Officer
Colin McCracken
Co-Founder
Joseph Brennan
Co-Founder
Matthew Hayes
Browse more venture capital transactions:
Prev: 2/8/2023: Surf Internet venture capital transaction
Next: 2/8/2023: Zypp Electric venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs